Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 17 | 2025 | 108 | 6.820 |
Why?
|
| Thrombosis | 8 | 2025 | 207 | 3.340 |
Why?
|
| Platelet Activation | 6 | 2023 | 31 | 1.840 |
Why?
|
| Influenza, Human | 2 | 2021 | 213 | 1.050 |
Why?
|
| Hemostasis | 4 | 2020 | 19 | 0.980 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2025 | 36 | 0.890 |
Why?
|
| Leukocytes | 1 | 2025 | 110 | 0.870 |
Why?
|
| Megakaryocytes | 4 | 2022 | 19 | 0.870 |
Why?
|
| Receptor, Adenosine A2B | 7 | 2014 | 11 | 0.840 |
Why?
|
| Adaptive Immunity | 2 | 2022 | 105 | 0.790 |
Why?
|
| Cardiovascular System | 1 | 2023 | 41 | 0.750 |
Why?
|
| Atherosclerosis | 5 | 2014 | 162 | 0.700 |
Why?
|
| Serine Endopeptidases | 1 | 2021 | 125 | 0.650 |
Why?
|
| Plague | 1 | 2020 | 23 | 0.640 |
Why?
|
| Yersinia pestis | 1 | 2020 | 33 | 0.640 |
Why?
|
| Virion | 1 | 2020 | 122 | 0.600 |
Why?
|
| Betacoronavirus | 2 | 2020 | 182 | 0.600 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 206 | 0.560 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 220 | 0.550 |
Why?
|
| Immunity, Innate | 2 | 2022 | 829 | 0.550 |
Why?
|
| DNA Viruses | 1 | 2018 | 16 | 0.550 |
Why?
|
| Herpesviridae | 1 | 2018 | 15 | 0.550 |
Why?
|
| Influenza A virus | 1 | 2019 | 122 | 0.530 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2019 | 104 | 0.530 |
Why?
|
| Toll-Like Receptors | 2 | 2020 | 434 | 0.520 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 170 | 0.510 |
Why?
|
| RNA, Viral | 1 | 2018 | 267 | 0.500 |
Why?
|
| Pandemics | 2 | 2020 | 692 | 0.490 |
Why?
|
| Apoptosis | 1 | 2021 | 1100 | 0.470 |
Why?
|
| Membrane Glycoproteins | 2 | 2019 | 667 | 0.450 |
Why?
|
| Adenosine | 2 | 2012 | 79 | 0.450 |
Why?
|
| MicroRNAs | 2 | 2020 | 714 | 0.440 |
Why?
|
| Enterovirus B, Human | 1 | 2015 | 17 | 0.440 |
Why?
|
| Coxsackievirus Infections | 1 | 2015 | 12 | 0.440 |
Why?
|
| Animals | 21 | 2026 | 21493 | 0.420 |
Why?
|
| Cardiovirus Infections | 1 | 2014 | 14 | 0.410 |
Why?
|
| Encephalomyocarditis virus | 1 | 2014 | 15 | 0.410 |
Why?
|
| Myocarditis | 1 | 2015 | 68 | 0.410 |
Why?
|
| Humans | 25 | 2026 | 65837 | 0.390 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2012 | 12 | 0.380 |
Why?
|
| Inflammation | 10 | 2022 | 1199 | 0.370 |
Why?
|
| Hyperlipidemias | 1 | 2011 | 35 | 0.350 |
Why?
|
| Mice, Knockout | 10 | 2019 | 2168 | 0.330 |
Why?
|
| Endothelial Cells | 2 | 2026 | 216 | 0.320 |
Why?
|
| Disease Models, Animal | 6 | 2026 | 2329 | 0.250 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 877 | 0.250 |
Why?
|
| Mice | 13 | 2026 | 11185 | 0.240 |
Why?
|
| Gain of Function Mutation | 1 | 2026 | 20 | 0.230 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2025 | 14 | 0.230 |
Why?
|
| Circulating Tumor DNA | 1 | 2025 | 11 | 0.230 |
Why?
|
| DNA, Neoplasm | 1 | 2025 | 62 | 0.230 |
Why?
|
| Male | 10 | 2025 | 31406 | 0.220 |
Why?
|
| Fetus | 1 | 2025 | 103 | 0.220 |
Why?
|
| Female | 11 | 2025 | 34423 | 0.220 |
Why?
|
| Ultraviolet Rays | 1 | 2026 | 153 | 0.220 |
Why?
|
| Neutrophils | 2 | 2019 | 396 | 0.200 |
Why?
|
| Blotting, Western | 3 | 2021 | 611 | 0.200 |
Why?
|
| Neoplasms | 2 | 2025 | 1377 | 0.200 |
Why?
|
| Skin | 1 | 2026 | 436 | 0.180 |
Why?
|
| A549 Cells | 1 | 2021 | 39 | 0.170 |
Why?
|
| Adult | 4 | 2025 | 17575 | 0.170 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2021 | 139 | 0.170 |
Why?
|
| Hibernation | 1 | 2020 | 10 | 0.160 |
Why?
|
| Ursidae | 1 | 2020 | 12 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2014 | 605 | 0.160 |
Why?
|
| Risk Factors | 3 | 2017 | 5476 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 2026 | 926 | 0.150 |
Why?
|
| Aged | 3 | 2025 | 15146 | 0.150 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 63 | 0.150 |
Why?
|
| Endocytosis | 1 | 2020 | 152 | 0.150 |
Why?
|
| Middle Aged | 4 | 2025 | 18498 | 0.150 |
Why?
|
| Blood Vessels | 2 | 2012 | 63 | 0.150 |
Why?
|
| Complement C3 | 1 | 2019 | 61 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 279 | 0.140 |
Why?
|
| Extracellular Traps | 1 | 2019 | 45 | 0.140 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 154 | 0.140 |
Why?
|
| Collagen | 2 | 2016 | 135 | 0.140 |
Why?
|
| Mean Platelet Volume | 1 | 2017 | 2 | 0.130 |
Why?
|
| Dietary Fats | 3 | 2014 | 181 | 0.130 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 799 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 3506 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 542 | 0.120 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2016 | 4 | 0.120 |
Why?
|
| Forecasting | 1 | 2017 | 231 | 0.120 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 113 | 0.120 |
Why?
|
| Thrombophilia | 1 | 2016 | 14 | 0.120 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 235 | 0.120 |
Why?
|
| Fibrinolytic Agents | 1 | 2017 | 183 | 0.110 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2012 | 22 | 0.110 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 741 | 0.110 |
Why?
|
| Obesity | 2 | 2014 | 1281 | 0.110 |
Why?
|
| Platelet Aggregation | 2 | 2016 | 24 | 0.110 |
Why?
|
| Hypertension | 1 | 2020 | 618 | 0.110 |
Why?
|
| Platelet Count | 1 | 2014 | 27 | 0.100 |
Why?
|
| Cell Degranulation | 1 | 2014 | 23 | 0.100 |
Why?
|
| Secretory Vesicles | 1 | 2014 | 24 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 203 | 0.100 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2014 | 9 | 0.100 |
Why?
|
| Membrane Transport Proteins | 1 | 2015 | 135 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 180 | 0.100 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2014 | 145 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 316 | 0.090 |
Why?
|
| Foam Cells | 1 | 2012 | 5 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2017 | 529 | 0.090 |
Why?
|
| Signal Transduction | 3 | 2012 | 3170 | 0.090 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 274 | 0.090 |
Why?
|
| Sex Factors | 1 | 2015 | 995 | 0.090 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 116 | 0.080 |
Why?
|
| Vascular Diseases | 1 | 2012 | 83 | 0.080 |
Why?
|
| Macrophages | 2 | 2014 | 1042 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2008 | 53 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1583 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1291 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2014 | 415 | 0.080 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 65 | 0.080 |
Why?
|
| Prognosis | 1 | 2015 | 1794 | 0.080 |
Why?
|
| Adenosine Diphosphate | 1 | 2010 | 44 | 0.080 |
Why?
|
| Homeostasis | 1 | 2012 | 383 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 911 | 0.080 |
Why?
|
| Glucose | 1 | 2012 | 478 | 0.070 |
Why?
|
| Biomarkers | 1 | 2015 | 1502 | 0.070 |
Why?
|
| Massachusetts | 1 | 2015 | 2158 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5682 | 0.070 |
Why?
|
| Up-Regulation | 3 | 2020 | 377 | 0.070 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2008 | 17 | 0.070 |
Why?
|
| NADPH Oxidases | 1 | 2008 | 69 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2012 | 1635 | 0.070 |
Why?
|
| Receptors, CXCR4 | 1 | 2008 | 43 | 0.070 |
Why?
|
| Liver | 1 | 2011 | 875 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2006 | 218 | 0.060 |
Why?
|
| Liquid Biopsy | 1 | 2025 | 5 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 922 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2025 | 73 | 0.060 |
Why?
|
| Platelet Adhesiveness | 2 | 2016 | 7 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 738 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2025 | 664 | 0.050 |
Why?
|
| Nanomedicine | 1 | 2022 | 24 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 1292 | 0.040 |
Why?
|
| Adenosine A2 Receptor Agonists | 2 | 2012 | 7 | 0.040 |
Why?
|
| Immunity | 1 | 2022 | 107 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 183 | 0.040 |
Why?
|
| Antithrombin III | 1 | 2020 | 15 | 0.040 |
Why?
|
| Angiotensins | 1 | 2020 | 3 | 0.040 |
Why?
|
| Seasons | 1 | 2020 | 140 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 690 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 140 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 226 | 0.040 |
Why?
|
| Rats | 2 | 2016 | 2005 | 0.040 |
Why?
|
| Pregnancy | 1 | 2025 | 2401 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2020 | 439 | 0.030 |
Why?
|
| Inpatients | 1 | 2020 | 322 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 2 | 2008 | 140 | 0.030 |
Why?
|
| Bone Marrow Cells | 2 | 2008 | 237 | 0.030 |
Why?
|
| Integrin alpha2beta1 | 1 | 2016 | 1 | 0.030 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2016 | 7 | 0.030 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 14 | 0.030 |
Why?
|
| Platelet Factor 4 | 1 | 2016 | 12 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 1573 | 0.030 |
Why?
|
| Bacteroidaceae Infections | 1 | 2014 | 3 | 0.030 |
Why?
|
| Porphyromonas gingivalis | 1 | 2014 | 17 | 0.030 |
Why?
|
| Thrombin | 1 | 2014 | 23 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2016 | 419 | 0.030 |
Why?
|
| Imidazoles | 1 | 2014 | 82 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 149 | 0.020 |
Why?
|
| Pyridines | 1 | 2014 | 120 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 514 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 216 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2012 | 34 | 0.020 |
Why?
|
| Receptors, Adenosine A2 | 1 | 2012 | 4 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 235 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 269 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 436 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2012 | 61 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 963 | 0.020 |
Why?
|
| Cholesterol | 1 | 2012 | 262 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2010 | 1 | 0.020 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 2010 | 4 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2010 | 9 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2031 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2010 | 144 | 0.020 |
Why?
|
| Femoral Artery | 1 | 2010 | 105 | 0.020 |
Why?
|
| NADPH Oxidase 4 | 1 | 2008 | 7 | 0.020 |
Why?
|
| Insulin | 1 | 2012 | 697 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 676 | 0.020 |
Why?
|
| Aorta | 1 | 2008 | 108 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2008 | 238 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 625 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 626 | 0.020 |
Why?
|
| Leukocyte Rolling | 1 | 2006 | 3 | 0.020 |
Why?
|
| P-Selectin | 1 | 2006 | 7 | 0.020 |
Why?
|
| E-Selectin | 1 | 2006 | 19 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 54 | 0.020 |
Why?
|
| Phenotype | 1 | 2010 | 1236 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2008 | 398 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2006 | 257 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2194 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 1044 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 3777 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 965 | 0.010 |
Why?
|